Comment on: concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza

J Antimicrob Chemother. 2008 Aug;62(2):426-8; author reply 428-9. doi: 10.1093/jac/dkn167. Epub 2008 Apr 22.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use*
  • Bacterial Adhesion
  • Disease Outbreaks / prevention & control*
  • Humans
  • Influenza, Human / prevention & control*
  • Lectins / metabolism
  • Neuraminidase / pharmacology
  • Neuraminidase / therapeutic use*
  • Pneumococcal Infections
  • Recombinant Proteins / pharmacology
  • Recombinant Proteins / therapeutic use*
  • Respiratory Mucosa / chemistry
  • Streptococcus pneumoniae / physiology

Substances

  • Antiviral Agents
  • Lectins
  • Recombinant Proteins
  • Neuraminidase